Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) EV/Sales
As of 16 October 2026, Becton, Dickinson and Company (BDX) trades at a EV/Sales of 2.9×. Over the past ten years it has ranged from 2.4× (June 2026) to 5.2× (January 2018); the current reading is higher than 16% of that period. That is in line with the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.7× | (22.53%) |
| FY2024 | 3.5× | (4.94%) |
| FY2023 | 3.7× | 10.80% |
| FY2022 | 3.3× | (8.28%) |
| FY2021 | 3.6× | (9.19%) |
| FY2020 | 4.0× | (1.31%) |
| FY2019 | 4.0× | (7.81%) |
| FY2018 | 4.4× | 41.56% |
| FY2017 | 3.1× | 1.77% |
| FY2016 | 3.0× | 2.66% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.4× | (7.27%) |
| Mar 2026 | 2.6× | (3.78%) |
| Dec 2025 | 2.7× | 0.10% |
| Sep 2025 | 2.7× | (3.48%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDLN Medline Inc. compare | 1.4× |
| BAX Baxter International Inc. compare | 1.8× |
| SOLV Solventum Corporation compare | 2.4× |
| BDX Becton, Dickinson and Company | 2.9× |
| ALC Alcon compare | 3.3× |
| RMD ResMed Inc. compare | 6.0× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| RGEN Repligen Corporation compare | 12.3× |
| ISRG Intuitive Surgical, Inc. compare | 13.2× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement